Skip to main navigation Skip to search Skip to main content

Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study

  • Carole Desthieux
  • , Benjamin Granger
  • , Andra Rodica Balanescu
  • , Peter Balint
  • , Jürgen Braun
  • , Juan D. Canete
  • , Turid Heiberg
  • , Philip S. Helliwell
  • , Umut Kalyoncu
  • , Tore K. Kvien
  • , Uta Kiltz
  • , Dora Niedermayer
  • , Kati Otsa
  • , Rossana Scrivo
  • , Josef Smolen
  • , Tanja A. Stamm
  • , Douglas J. Veale
  • , Kurt de Vlam
  • , Maarten de Wit
  • , Laure Gossec
  • Sorbonne Université
  • Carol Davila University of Medicine and Pharmacy
  • National Institute of Rheumatology and Physiotherapy Budapest
  • Ruhr University Bochum
  • Hospital Clínic de Barcelona
  • Østfold University College
  • University of Leeds
  • Diakonhjemmet Hospital
  • East - Tallinn Central Hospital
  • University of Rome La Sapienza
  • Medical University of Vienna
  • University College Dublin
  • KU Leuven
  • Patient Research Partner

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)

Abstract

Objective: Patient-physician discordance in global assessment of disease activity concerns one-third of patients, but what does it reflect? We aimed to assess patient-physician discordance in psoriatic arthritis (PsA) and patient-reported domains of health (physical and psychological) associated with discordance. Methods: We analyzed the PsAID (Psoriatic Arthritis Impact of Disease), a cross-sectional, multicenter European study of patients with PsA according to expert opinion. Patient global assessment (PGA) and physician global assessment (PhGA) were rated on a 0–10 numeric rating scale. Discordance was defined as the difference (PGA−PhGA) and as the absolute difference |PGA−PhGA| ≥3 points. Determinants of PGA−PhGA were assessed by a stepwise multivariate linear regression among 12 physical and psychological aspects of impact: pain, skin problems, fatigue, ability to work/leisure, functional incapacity, feeling of discomfort, sleep disturbance, anxiety/fear, coping, embarrassment/shame, social participation, and depressive affects. Results: In 460 patients (mean ± SD age 50.6 ± 12.9 years, 52.2% female, mean ± SD disease duration 9.5 ± 9.5 years, mean ± SD Disease Activity Index for Psoriatic Arthritis score 30.8 ± 32.4, and 40.4% undergoing treatment with biologic agents), the mean ± SD PGA was higher than the mean PhGA, with a mean absolute difference of 1.9 ± 1.8 points. Discordance defined by |PGA−PhGA| ≥3 of 10 concerned 134 patients (29.1%), and 115 patients (85.8% of the patients with discordance) had PGA>PhGA. Higher fatigue (β = 0.14), lower self-perceived coping (β = 0.23), and impaired social participation (β = 0.16) were independently associated with a higher difference (PGA−PhGA). Conclusion: Discordance concerned 29.1% of these patient/physician dyads, mainly by PGA>PhGA. Factors associated with discordance were psychological rather than physical domains of health. Discordance was more frequent in patients in remission, indicating more work is needed on the patient perspective regarding disease activity.

Original languageEnglish
Pages (from-to)1606-1611
Number of pages6
JournalArthritis Care and Research
Volume69
Issue number10
DOIs
Publication statusPublished - Oct 2017

Fingerprint

Dive into the research topics of 'Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study'. Together they form a unique fingerprint.

Cite this